Market cap
$703 Mln
Revenue (TTM)
$305 Mln
P/E Ratio
425.7
P/B Ratio
2.2
Div. Yield
0.2 %
| CryoLife Inc (CRY) | Sientra (SIEN) | |
|---|---|---|
Market cap ($ Mln) |
703 | -- |
Revenue ($ Mln) |
305 | 93 |
Net Profit ($ Mln) |
-15.09 | -69.04 |
Net Margin (%) |
-5.02 | -74.27 |
RoE (%) |
-4.95 | -- |
Price to Earnings |
425.71 | -- |
Price-To-Book |
2.22 | -- |
Income Statement ($ Mln)
| CryoLife Inc (CRY) | Sientra (SIEN) | |
|---|---|---|
|
Operating Revenue
|
304.96 | 80.68 |
|
Cost of Revenue
|
104.57 | 36.35 |
|
Gross Profit
|
197.51 | 44.34 |
|
Operating Expenses
|
208.01 | 90.69 |
|
Operating Profit (EBIT)
|
-7.62 | -46.35 |
|
Other Income
|
-4.27 | -10.15 |
|
Profit before Tax
|
-12.76 | -62.50 |
|
Provision for Tax
|
2.33 | 0.02 |
|
Profit after Tax (Net Income)
|
-15.09 | -62.52 |
|
Minority Interest
|
0.00 | -- |
|
Consolidated Profit
|
-15.07 | -62.48 |
Liabilities ($ Mln)
| CryoLife Inc (CRY) | Sientra (SIEN) | |
|---|---|---|
|
Shareholder's Funds
|
297.49 | 40.86 |
|
Minority Interest
|
0.00 | -- |
|
Non-Current Liabilities
|
441.53 | 79.03 |
|
Current Liabilities
|
42.84 | 80.02 |
|
Total Liabilities
|
793.05 | 199.90 |
Assets ($ Mln)
| CryoLife Inc (CRY) | Sientra (SIEN) | |
|---|---|---|
|
Non-Current Assets
|
3.49 | 59.13 |
|
Current Assets
|
244.53 | 140.77 |
|
Total Assets
|
793.05 | 199.90 |
|
Total Debt*
|
0.00 | 64.67 |
|
Net Current Assets
|
0.00 | 60.76 |
Cashflow ($ Mln)
| CryoLife Inc (CRY) | Sientra (SIEN) | |
|---|---|---|
|
Cash From Operating Activities
|
-2.59 | -42.50 |
|
Cash Flow from Investing Activities
|
5.66 | 3.33 |
|
Cash from Financing Activities
|
-12.22 | 35.94 |
|
Net Cash Inflow / Outflow
|
-9.15 | -32.64 |
Ratios
Profitability Ratios
| CryoLife Inc (CRY) | Sientra (SIEN) | |
|---|---|---|
|
ROCE (%)
|
-2.30 | -73.49 |
|
ROE (%)
|
-4.95 | -310.27 |
|
ROA (%)
|
-1.61 | -33.90 |
|
EBIT Margin (%)
|
1.32 | -- |
|
Net Margin (%)
|
-5.02 | -77.49 |
|
Cash Profit Margin (%)
|
0.00 | -- |
Growth Ratios
| CryoLife Inc (CRY) | Sientra (SIEN) | |
|---|---|---|
|
Revenue Growth (%)
|
18.26 | 0.13 |
|
EBIT Growth (%)
|
6.04 | -- |
|
Net Profit Growth (%)
|
-14.67 | 30.49 |
|
EPS Growth (%)
|
-- | -- |
|
Book Value Growth (%)
|
-- | -- |
Valuation Ratios
| CryoLife Inc (CRY) | Sientra (SIEN) | |
|---|---|---|
|
Price / Earnings
|
-- | -- |
|
Price / Book Value
|
-- | -- |
|
Dividend Yield (%)
|
-- | -- |
|
EV/EBITDA
|
11.79 | -0.36 |
|
Market Cap ($ Cr)
|
-- | -- |
Solvency Ratios
| CryoLife Inc (CRY) | Sientra (SIEN) | |
|---|---|---|
|
Debt to Equity
|
1.03 | 1.58 |
|
Short term debt to equity ratio
|
0.01 | 0.05 |
|
Current Ratio
|
5.71 | 1.76 |
|
Quick Ratio
|
3.93 | 1.10 |
|
Interest Coverage
|
0.24 | -5.62 |
Operating Efficiency Ratios
| CryoLife Inc (CRY) | Sientra (SIEN) | |
|---|---|---|
|
Debtors to sales (%)
|
19.54 | 41.03 |
|
Asset Turnover
|
0.32 | 0.44 |
|
Receivable days
|
65.30 | 128.13 |
|
Inventory Days
|
270.38 | 510.28 |
|
Payable days
|
36.08 | 69.87 |
|
Cash Conversion Cycle
|
299.60 | 568.55 |